TGA Approval

NUBEQA darolutamide 300 mg tablet blister pack (316417)

ARTG ID

316417

ARTG Name

NUBEQA darolutamide 300 mg tablet blister pack

Sponsor

Bayer Australia Ltd

ARTG Date

February 26, 2020

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BAYER AUSTRALIA LTD

https://medical-cdn.nocode.com/drug_tga/ecf73514b7bde1035c24861cbfac73fd.pdf

https://medical-cdn.nocode.com/drug_tga/c6530f3b8c262a20b71e88f23b62ac06.pdf

Ingredient Name

darolutamide

Empowering clinical research with data-driven insights and AI-powered tools.

NUBEQA darolutamide 300 mg tablet blister pack (316417) - TGA 批准文号 | MedPath